[Federal Register Volume 63, Number 186 (Friday, September 25, 1998)] [Rules and Regulations] [Page 51299] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: X98-10925] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 5 Delegations of authority and Organization CFR Correction In Title 21 of the Code of Federal Regulations, parts 1 to 99, revised as of Apr. 1, 1998, page 42, Sec. 5.33(c) was inadvertently removed and is reinstated to read as follows: 5.33 Premarket approval of a product that is or contains a biologic, a device, or a drug. * * * * * (c) The Director, Deputy Center Director for Review Management, and Deputy Center Director for Pharmaceutical Science, Center for Drug Evaluation and Research (CDER); and the Directors of the Offices of Drug Evaluation I, II, III, IV, and V, Office of Review Management, CDER. BILLING CODE 1505-01-D